Emcure Pharmaceuticals Announces FY2026 Investor Presentation
Emcure Pharmaceuticals has released its investor presentation for the financial year ending March 31, 2026, on BSE.
Read articleAI-assisted articles on quarterly results, exchange filings, and earnings calls — tied to the companies you follow.
4 articles published
Results for “EMCURE” · in Corporate announcement — Clear filters
Emcure Pharmaceuticals has released its investor presentation for the financial year ending March 31, 2026, on BSE.
Read articleEmcure Pharmaceuticals has submitted its investor presentation to NSE, providing stakeholders with updated corporate information.
Read articleEmcure Pharmaceuticals has recommended a final dividend for the financial year 2025-26, subject to shareholder approval at the upcoming annual general meeting.
Read articleEmcure Pharmaceuticals board has recommended a final dividend for FY 2025-26. The proposal awaits shareholder approval at the upcoming annual general meeting.
Read articleNSE & BSE filings, quarterly results, insider trades, and smart volume alerts — delivered on WhatsApp or Telegram. No separate app to install.
"ZTOX alerts helped me catch a multi-bagger stock last quarter. The insider deals notifications are absolutely game-changing for retail investors."
No credit card required. Connect WhatsApp or Telegram in minutes.